Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can eating sooner after colon surgery improve recovery?

NCT ID NCT06805123

Knowledge-focused Sponsor: Pusan National University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 02, 2026 · Updated 4 times

Summary

This study looks at whether starting to eat within 24 hours after a colon polyp removal procedure (called ESD) is safe and better than waiting longer. About 204 patients will be randomly assigned to either early feeding (water after 2 hours, then liquid diet) or delayed feeding (fasting until the next day). The goal is to see if early eating leads to fewer complications like bleeding, and improves patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dietary restart timing (early vs. delayed feeding)
What this could lead to
If early feeding is safe, patients may be able to eat sooner after colorectal ESD, leading to shorter hospital stays and higher satisfaction.
What could go wrong
This is a relatively small, early-stage trial (204 participants) and may not detect rare complications. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

204 people

The number who actually took part.

Started

Feb 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligible patients were adults (≥19 years) scheduled to undergo colorectal ESD who met one or more of the following indications: (1) differentiated early colorectal cancer ≤5 cm without ulceration and confined to the mucosa, (2) laterally spreading tumor ≥2 cm, (3) sessile polyp ≥2 cm, (4) adenoma with fibrosis, (5) differentiated early colorectal cancer without lymph node metastasis, or (6) colorectal subepithelial lesion. These indications correspond to the reimbursement criteria for colorectal ESD under the Korean National Health Insurance system. The exclusion criteria were as follows: untreated colorectal cancer, active inflammatory bowel disease, coagulopathy or prothrombin time-international normalized ratio \>1.5 despite medical correction, pregnancy, endoscopically unmanageable perforation or bleeding during the procedure, and refusal to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal neoplasms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal neoplasms Endoscopic submucosal dissection

Contacts and locations

Locations

  • Inje university busan paik hospital

    Busan, 47392, South Korea

  • Kosin university gospel hospital

    Busan, 49267, South Korea

  • Pusan National University Hospital

    Busan, 49241, South Korea

  • Pusan National University Yangsan Hospital

    Yangsan, 50612, South Korea

  • Ulsan university hospital

    Ulsan, 44033, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.